Skip to main content
Premium Trial:

Request an Annual Quote

Verdezyne to Synthesize Genes for Syngenta

NEW YORK (GenomeWeb News) — The synthetic biology company Verdezyne will develop novel genes for Syngenta, which will test them for enzyme expression in plants, Verdezyne said today.

Formerly called Coda Genomics, Verdezyne uses computational algorithms to design and synthesize gene libraries used to make proteins, metabolic pathways, and microorganisms, which are in turn used to make platform chemicals and biofuels.

Syngenta sells genetically modified plant seeds and biology-based crop protection technologies.

Financial terms of the agreement were not released.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.